Nuvectis Pharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nuvectis Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Nuvectis Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 17.2M shares, a 6.99% increase year-over-year.
  • Nuvectis Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 15.6M shares, a 22.9% increase from 2022.
  • Nuvectis Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 12.7M shares, a 197% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 17.2M +1.13M +6.99% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 16.9M +1.72M +11.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 16.6M +1.84M +12.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 15.6M +2.9M +22.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 16.1M +2.05M +14.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 15.2M +2.46M +19.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 14.7M +5.57M +60.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 12.7M +8.39M +197% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 14.1M +9.54M +212% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 12.7M +8.56M +206% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 9.16M +5.26M +135% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 4.27M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 4.51M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 4.16M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 3.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.